Medistep Healthcare Board of Directors
Get the latest insights into the leadership at Medistep Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Girdhari Lal Prajapat | Managing Director |
| Mr. Dabhi Vipul Gobarbhai | Executive Director |
| Ms. Prajapati Hetalben Girdharilal | Non Executive Director |
| Mr. Khoda Anandbhai Jitendrabhai | Independent Director |
| Mr. Dodiya Kapilbhai Raysinhbhai | Independent Director |
Medistep Healthcare Share price
MEDISTEP
21.55
1.05 (-4.65%)Last updated on 20 Feb, 2026 | 09:50 IST
BUYSELL
Today's High
21.55
Today's Low
21.55
52 Week Low
21.00
52 Week High
53.00
Free Demat with Zero AMC*
Medistep Healthcare FAQs
The board at Medistep Healthcare consists of experienced professionals, including Mr. Girdhari Lal Prajapat , Mr. Dabhi Vipul Gobarbhai , and others, overseeing the company’s strategic and corporate governance.
Directors at Medistep Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Girdhari Lal Prajapat is the current chairman at Medistep Healthcare.
Executive directors at Medistep Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Medistep Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Medistep Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
